Browse > Article
http://dx.doi.org/10.3961/jpmph.2008.41.6.407

The Association of Cardiovascular Risk Factors with Nonalcoholic Fatty Liver Disease in Health Checkup Examinees  

Yu, Jae-Hee (Graduate School of Public Health, The Catholic University of Korea)
Lee, kang-Sook (Department of Prevention Medicine & Catholic Industrial Medical Center, The Catholic University of Korea)
Lee, Seon-Young (Department of Prevention Medicine & Catholic Industrial Medical Center, The Catholic University of Korea)
Hong, A-Rum (Department of Prevention Medicine & Catholic Industrial Medical Center, The Catholic University of Korea)
Park, Yong-Sang (Health Promotion Center, St Mary's Hospital The Catholic University of Korea)
Publication Information
Journal of Preventive Medicine and Public Health / v.41, no.6, 2008 , pp. 407-412 More about this Journal
Abstract
Objectives: The purpose of this study was to evaluate the relationship of nonalcoholic fatty liver and cardiovascular risk factors. Methods: This study was conducted to investigate the association of nonalcoholic fatty liver and cardiovascular risk factors for adult men (n=2976) and women (n=2442) who were over 19 years old, after excluding the HBsAg(+) or anti-HCV(+) patients and the men and women with increased alcohol intake (men: 40g/week, women: 20g/week). Results: Compared with the normal liver subjects, the nonalcoholic fatty liver subjects showed a significantly increased frequency of abnormal systolic blood pressure (${geq}120mmHg$), fasting blood sugar (${\geq}100mg/dL$), total cholesterol ($({\geq}200 mg/dL$), triglyceride ($({\geq}150mg/dL$), high density lipoprotein cholesterol (<40 mg/dL), low density lipoprotein cholesterol ($({\geq}130g\; m/dL$) and abdominal obesity in men, and all these measures were significantly increased in the women except for abnormal HDL cholesterol. After adjusting for the body mass index, age, smoking, exercise and a nonalcoholic liver, the odds ratios of an abnormal waist hip ratio were 1.35(95% Confidence Interval=1.05-4.72) in the mild fatty liver, 1.61 (1.19-2.18) in the moderate fatty liver, 2.77(1.57-4.92) in the severe fatty liver compared with a normal liver. The adjusted odds ratios for abnormal fasting blood sugar were 1.26(1.03-1.53) in the mild fatty liver, 1.62(1.27-2.06) in the moderate fatty Iiver and 1.77(1.12-2.78) in the severe fatty liver. The adjusted odds ratios for abnormal triglyceride were 1.38(1.11-1.72) in the mild fatty liver, 1.73(0.33-2.24) in the moderate fatty liver and 1.91 (1.17-3.10) in the severe fatty liver of men. Adjusted odds ratios for abnormal triglyceride were 1.50(1.04-2.15) in mild, 1.71(1.07-2.68) in moderate, 1.81(0.69-4.38) in severe fatty liver of women. Conclusions: The nonalcoholic fatty liver subjects had more cardiovascular risk factors compared with the normal liver subjects. Thus, prevention and treatment of the nonalcoholic fatty liver is necessary by lifestyle modifications such as restriction of alcohol intake, no smoking, exercise and adequate eating habits.
Keywords
Nonalcoholic fatty liver; Cardiovascular risk factors;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
Times Cited By SCOPUS : 3
연도 인용수 순위
1 Clark JM, Brancati FL, Diehl AM. Nonal coholic fatty liver disease. Gastroenterology 2002; 122(6): 1649-1657   DOI   ScienceOn
2 Yeon JE. Nonalcoholic fatty liver disease: Pathogenesis and treatment. Korean J Med 2006; 70(3): 246-252.(Korean)
3 Jin SY. Fatty liver. Korean J Hepatol 2006; 12(1): 112-115.(Korean)   PUBMED
4 Kim SM, Kim JA, Han JH, Cho KH, Yoon D. Nonalcoholic fatty liver disease and metabolic syndrome in nonobese, nondiabetic adults. Korean J Obes 2006; 15(1): 44-51.(Korean)
5 Park SK, Lee HJ, Lee DH, Lee SK, Chun BY, Kim SA, et al. Associations of non alcoholic fatty liver with the metabolic syndrome and serum carotenoids. J Prev Med Public Health 2008; 41(1): 39-44.(Korean)   과학기술학회마을   DOI   ScienceOn
6 Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26(11): 3160-3167   DOI   ScienceOn
7 Kang JH, Lee SW, Lee HS, Cho CY, Yu BY. The relation of nonalcoholic fatty liver sisease to metabolic syndrome. J Korean Acad Fam Med 2004; 25(10): 746-753.(Korean)
8 Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study. Hepatology 2000; 32(4 Pt 1): 689-692   DOI   ScienceOn
9 Kim KS. The relationship between fatty liver and parameters of metabolic syndrome in the non alcoholic health screen examinees. Kosin Med J 2006; 21(1): 207-217.(Korean)
10 Knobler H, Schattner A, Zhornicki T, Malnick SD, Keter D, Sokolovskaya N, et al. Fatty liver: An additional and treatable feature of the insulin resistance syndrome. QJM 1999; 92(2): 73-79   DOI   ScienceOn
11 Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 2005; 129(1): 113-121   DOI   ScienceOn
12 Akahoshi M, Amasaki Y, Soda M, Tominaga T, Ichimaru S, Nakashima E, et al. Correlation between fatty liver and coronary risk factors: A population study of elderly men and women in Nagasaki, Japan. Hypertens Res 2001; 24(4): 337-343   DOI   ScienceOn
13 Nah EH, Park JY. Metabolic characteristics and associated factors of nonalcoholic fatty liver disease diagnosed at medical checkups. Korean J Lab Med 2008; 28(3): 244-250.(Korean)   DOI   ScienceOn
14 McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 2002; 34(3): 255-262   DOI   PUBMED   ScienceOn
15 Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003; 9(3): 237-252   PUBMED
16 McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 2004; 8(3): 521-533   DOI   PUBMED   ScienceOn
17 Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003; 37(4): 909-916   DOI   ScienceOn
18 Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120(5): 1183-1192   DOI   ScienceOn
19 Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346(16): 1221-1231   DOI   PUBMED   ScienceOn
20 Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997; 126(2): 137-145   DOI   PUBMED   ScienceOn
21 Pares A, Tresserras R, Nunez I, Cerralbo M, Plana P, Pujol FJ, et al. Prevalence and factors associated to the presence of fatty liver in apparently healthy adult men. Med Clin (Barc) 2000; 114(15): 561-565.(Spanish)   DOI   PUBMED   ScienceOn
22 Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999; 116(6): 1413-1419   DOI   ScienceOn
23 Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87(7): 3023-3028   DOI   ScienceOn
24 Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107(5): 450-455   DOI   PUBMED   ScienceOn
25 Kim HJ, Kim DJ, Kim SK, Kim SH, Rhee YM, Ahn CW, et al. Metabolic abnormalities according to severity of non-alcoholic fatty liver disease in Korean adults. J Korean Soc Endocrinol 2002; 17(4): 514-525.(Korean)
26 Seo SH, Lee HW, Park HW, Jang BG, Chung WJ, Park KS, et al. Prevalence and associated factors of nonalcoholic fatty liver disease in the health screen examinees. Korean J Med 2006; 70(1): 26-32.(Korean)
27 World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Geneva: WHO Department of Noncommunicable Disease Surveillance; 1999
28 Anderson AJ, Sobocinski KA, Freedman DS, Barboriak JJ, Rimm AA, Gruchow HW. Body fat distribution, plasma lipids, and lipoproteins. Arteriosclerosis 1988; 8(1): 88-94   DOI   PUBMED
29 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42(6): 1206-1252   DOI   ScienceOn
30 Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001; 50(8): 1844-1850   DOI   ScienceOn